105.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$106.06
Offen:
$105.935
24-Stunden-Volumen:
7.49M
Relative Volume:
0.55
Marktkapitalisierung:
$261.26B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
13.92
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
-1.12%
1M Leistung:
+0.41%
6M Leistung:
+32.97%
1J Leistung:
+5.81%
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MRK
Merck Co Inc
|
105.26 | 263.24B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,074.68 | 966.40B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
206.95 | 498.51B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
228.49 | 406.04B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
137.87 | 266.17B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck stock dips after hours as 2025 ends; MRK investors shift focus to Feb. 3 earnings - ts2.tech
Where is Merck & Co. (MRK) Headed? - Finviz
JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Los Angeles Capital Management LLC Buys 956,879 Shares of Merck & Co., Inc. $MRK - MarketBeat
Stonebridge Financial Group LLC Has $638,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Sax Wealth Advisors LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Has $126.51 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Smith Salley Wealth Management Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Calamos Advisors LLC Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by 3Chopt Investment Partners LLC - MarketBeat
FDA fast-tracks two Merck (MRK) drugs with blockbuster potential - MSN
FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential - Finviz
Merck: A Post-2028 Slowdown Doesn’t Kill The Long-Term Thesis (NYSE:MRK) - Seeking Alpha
Oak Harvest Investment Services Purchases 24,325 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fort Washington Investment Advisors Inc. OH Has $51.42 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year HighHere's What Happened - MarketBeat
Diversified Trust Co Purchases 18,187 Shares of Merck & Co., Inc. $MRK - MarketBeat
Chemung Canal Trust Co. Buys 13,285 Shares of Merck & Co., Inc. $MRK - MarketBeat
Farmers & Merchants Investments Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) S&P 500 ETF Scientific Infrastructure - Kalkine Media
Where is Merck & Co. (MRK) Headed According to Wall Street? - Finviz
November phase III successes led by HIV wins from Gilead, Merck - BioWorld MedTech
Merck & Co Unusual Options Activity - Benzinga
Norris Perne & French LLP MI Sells 36,819 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Ethic Inc. - MarketBeat
Merck (MRK) Stock Today: Latest News, Analyst Forecasts, and What Investors Should Watch Before Monday’s Open - ts2.tech
Valley National Advisers Inc. Acquires 25,843 Shares of Merck & Co., Inc. $MRK - MarketBeat
Institutional Investors Control 79% of Merck & Co., Inc. (NYSE:MRK) and Were Rewarded Last Week After Stock Increased 5.6% - 富途牛牛
3 Drug Stocks to Buy at a Discount - The Motley Fool
Merck (MRK) Stock Update: Weekend Wrap, Latest Headlines, Analyst Targets, and What to Watch Before Monday’s Open - ts2.tech
Merck & Co., Inc. $MRK Stock Holdings Lowered by Kempner Capital Management Inc. - MarketBeat
Merck & Co. Is Honored to Be Named to Forbes America's Best Employers List for the Eighth Year in a Row. - CSRwire
Merck & Co. Named as a 2022 Best Place to Work for LGBTQ+ Equality - CSRwire
Looking Into Merck & Co Inc's Recent Short Interest - Benzinga
Highland Capital Management LLC Sells 34,848 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck (MRK) is an inexpensive stock, says Jim Cramer - MSN
Pacer Advisors Inc. Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Secured Retirement Advisors LLC Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Cwm LLC Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Avanza Fonder AB Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck (MRK) Stock: Key News, Analyst Targets, and Catalysts to Know Before the Market Opens Dec. 26, 2025 - ts2.tech
Merck & Co. (MRK) Enters 2026 in the Spotlight: BMO Upgrade to $130, FDA Fast-Track Vouchers and TrumpRx Pricing Deal Reframe the Post-Keytruda Story - ts2.tech
Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum - ts2.tech
Bar Harbor Wealth Management Buys 14,147 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighWhat's Next? - MarketBeat
Vontobel Holding Ltd. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Hanson & Doremus Investment Management Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Swedbank AB Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Farther Finance Advisors LLC - MarketBeat
Exchange Traded Concepts LLC Has $7.99 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint - Kalkine Media
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):